FDA approves GSK's drug Nucala for severe asthma
November 04, 2015 at 18:06 PM EST
WASHINGTON, Nov 4 (Reuters) - GlaxoSmithKline Plc won U.S. regulatory approval for its drug Nucala to treat severe asthma, the Food and Drug Administration said on Wednesday.